scispace - formally typeset
G

Giuseppe Reimondo

Researcher at University of Turin

Publications -  115
Citations -  6749

Giuseppe Reimondo is an academic researcher from University of Turin. The author has contributed to research in topics: Mitotane & Adrenocortical carcinoma. The author has an hindex of 38, co-authored 106 publications receiving 5865 citations. Previous affiliations of Giuseppe Reimondo include University of Padua & Gonzaga University.

Papers
More filters
Journal ArticleDOI

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

TL;DR: It is confirmed that subjects undergoing computerized tomography scan of the chest in a screening program of lung cancer in Piedmont are presently able to identify incidentally discovered adrenal masses more often than in early years and that the prevalence of adrenal incidentalomas on CT images is approaching that of autopsy series.
Journal ArticleDOI

AME Position Statement on adrenal incidentaloma

TL;DR: Surgery is recommended for masses with suspicious radiological aspects and masses causing overt catecholamine or steroid excess and adrenalectomy may be considered when an adequate medical therapy does not reach the treatment goals of associated diseases potentially linked to hypercortisolism.
Journal ArticleDOI

Adrenal incidentaloma: a new cause of the metabolic syndrome?

TL;DR: Many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls.
Journal ArticleDOI

Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy

TL;DR: Serial bone densitometry evaluation during androgen deprivation therapy may allow the detection of patients with prostate cancer at risk for osteoporotic fractures, that is those with osteopenia or osteoporeosis at baseline and fast bone loss.